0
0
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Morgan Stanley analyst Matthew Harrison upgraded the rating for Gilead Sciences, Inc. (NASDAQ:GILD) from Equal-Weight to Overweight and raised the price target from $87 to $113. Gilead Sciences shares closed at $89.14 on Wednesday. See how other analysts view this stock.
- Citigroup analyst Jon Tower upgraded McDonald’s Corporation (NYSE:MCD) …
Full story available on Benzinga.com
Visited 1 times, 1 visit(s) today